Global Hydantoin Anticonvulsants Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2022 –2029 |
 Market Size (Base Year) |
USD 208.06 Million |
 Market Size (Forecast Year) |
USD 280.39 Million |
 CAGR |
% |
| Major Markets Players |
>全球乙内酰脲抗惊厥药市场，按药物（美芬妥英、磷苯妥英、乙苯妥英、苯妥英等）、应用（癫痫、神经外科、癫痫发作预防、神经外科期间或之后的癫痫发作预防、癫痫发作、癫痫持续状态）、剂量（粉末、注射、其他）、给药途径（肠内、肠外、局部、其他）、最终用户（医院、专科诊所、家庭护理、其他）、分销渠道（医院药房、零售药房、网上药房、其他）划分 - 行业趋势和预测至 2029 年
市场分析和规模
抗惊厥药是指用于治疗癫痫发作的一类药物。这些药物通常被称为抗癫痫药或抗癫痫药。癫痫是一种慢性中枢神经系统（神经系统）疾病，大脑活动异常，导致癫痫发作或出现奇怪的行为、感觉，在极少数情况下，甚至失去意识。双相情感障碍、边缘性人格障碍、纤维肌痛和神经性疼痛都可以用抗惊厥药治疗。癫痫可以随时随地袭击任何年龄段的任何人。根据英国癫痫协会 2019 年的数据，有超过 20 种药物可用于治疗癫痫，包括巴比妥类药物、羧酰胺类药物、氨基甲酸酯类药物和 GABA 类似物，以及超过 25 种仿制药。
Data Bridge Market Research 分析称，2021 年乙内酰脲抗惊厥药市场价值为 2.08058 亿美元，预计到 2029 年将达到 2.8039 亿美元，在 2022 年至 2029 年的预测期内复合年增长率为 3.80%。Data Bridge Market Research 团队策划的市场报告包括深入的专家分析、患者流行病学、管道分析、定价分析和监管框架。
报告范围和市场细分
|
报告指标 |
细节 |
|
预测期 |
2022 至 2029 年 |
|
基准年 |
2021 |
|
历史岁月 |
2020（可定制至 2019 - 2014） |
|
定量单位 |
收入（百万美元）、销量（单位）、定价（美元） |
|
涵盖的领域 |
药物（美芬妥英、磷苯妥英、乙苯妥英、苯妥英、其他）、应用（癫痫、神经外科、癫痫发作预防、神经外科手术期间或之后的癫痫发作预防、癫痫发作、癫痫持续状态）、剂量（粉末、注射剂、其他）、给药途径（肠内、肠外、局部、其他）、最终用户（医院、专科诊所、家庭护理、其他）、分销渠道（医院药房、零售药房、网上药房、其他） |
|
覆盖国家 |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
|
Market Players Covered |
Merck KGaA (Germany), Eisai Co., Ltd. (Japan), AstraZeneca (UK), Sanofi (France), Novartis AG (Switzerland), Abbott (US), F. Hoffmann-La Roche Ltd. (Switzerland), Teva Pharmaceutical Industries Ltd. (Ireland), Pfizer Inc. (US), GlaxoSmithKline plc (UK), WOCKHARDT (Mumbai), Novo Nordisk A/S (Denmark), Glenmark Pharmaceuticals Limited (India), Cipla Inc. (US), Bausch Health Companies Inc. (Canada), Otsuka America Pharmaceutical, Inc. (US), Johnson & Johnson Private Limited (US), Takeda Pharmaceutical Company Limited (Japan), Sumitomo Corporation (Japan), Biocon (India) |
|
Market Opportunities |
|
Market Definition
The pharmacological class hydantoins is mostly used to treat seizures (anticonvulsant or antiepileptic drugs). Hydantoins work by blocking the sodium channel, which is found throughout the nervous system. Sodium channels are activated, resulting in the transmission of electrical impulses and the release of neurotransmitters. Barbiturates are structurally similar to hydantoin anticonvulsants. They have a heterocyclic allantoin base.
Hydantoin Anticonvulsants Market Dynamics
Drivers
- Increasing prevalence of epilepsy
The rising prevalence of epilepsy is anticipated to influence the hydantoin anticonvulsants market's growth. Epilepsy affects roughly 50 million people globally, according to a report released by the World Health Organization (WHO) in January 2019. Furthermore, it is predicted that 2.4 million new cases of epilepsy are diagnosed each year around the world.
- Rising approval of anticonvulsant drugs
The increasing approval of anticonvulsant medicine approvals is expected to flourish the market’s growth rate during the forecast period of 2022-2029. Anticonvulsant medicine approvals from the US Food and Drug Administration (FDA) are increasing, which is boosting the hydantoin anticonvulsant market income. The FDA has authorized approximately 24 anticonvulsant medicines. The first medicine containing an active ingredient derived from marijuana was approved by the FDA in 2018 to treat rare, severe forms of epilepsy such Lennox-Gastaut syndrome and Dravet syndrome.
Furthermore, rising initiatives by public and private organizations to spread awareness will expand the hydantoin anticonvulsants market. Additionally, rising healthcare expenditure and changing lifestyle of people will result in the expansion of hydantoin anticonvulsants market. Along with this, rising geriatric population and favourable reimbursement policies will enhance the growth rate of the market.
Opportunities
- Increase in the number of research and development activities
Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the hydantoin anticonvulsants market growth. Along with this, rising drug approvals and launches will further propel the market’s growth rate.
Moreover, rising investment for the development of advanced technologies and increase in the number of emerging markets will further provide beneficial opportunities for the hydantoin anticonvulsants market growth during the forecast period.
Restraints/Challenges
On the other hand, the high cost associated with the drug development and distribution will obstruct the growth rate of market. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the hydantoin anticonvulsants market. Additionally, side effects of hydantoin anticonvulsants such as dizziness, irritability, drowsiness, fatigue, headache, and vertigo will act as market restrain and further impede the growth rate of market during the forecast period of 2022-2029.
This hydantoin anticonvulsants market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the hydantoin anticonvulsants market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Patient Epidemiology Analysis
Hydantoin anticonvulsants market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
COVID-19 Impact on Hydantoin Anticonvulsants Market
自 2019 年 12 月出现以来，COVID-19 病毒已传播到地球上几乎每个国家，促使世界卫生组织 (WHO) 宣布其为公共卫生紧急事件。这可以归因于其各自的制造和供应链运营严重中断，因此是世界各国政府实施的多次预防性封锁和其他限制的结果。乙内酰脲抗惊厥药市场也不例外。此外，由于大多数人的整体经济状况受到此次疫情的不利影响，消费者偏好有所下降，因为人们现在更加专注于从预算中消除非必要开支。在预测期内，上述因素可能会对乙内酰脲抗惊厥药市场的收入轨迹产生负面影响。然而，现在 COVID-19 疫苗随时可用，许多当局正在努力确保不间断地供应救命药物和疫苗。因此，预计未来市场将趋于稳定。
全球乙内酰脲抗惊厥药市场范围
乙内酰脲抗惊厥药市场根据药物、应用、剂量、给药途径、最终用户和分销渠道进行细分。这些细分市场之间的增长情况将帮助您分析行业中增长缓慢的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。
药品
- 美芬妥英
- 磷苯妥英
- 乙妥英
- 苯妥英
- 其他
应用
- 癫痫
- 神经外科
- 癫痫预防
- 神经外科手术期间或之后的癫痫预防
- 癫痫
- 癫痫持续状态
剂量
- 注射
- 粉末
- 其他的
给药途径
- 肠内
- 肠外
- 主题
- 其他的
最终用户
- 医院
- 专科诊所
- 家庭护理
- 其他的
分销渠道
- 医院药房
- 零售药店
- 网上药店
- 其他的
乙内酰脲抗惊厥药市场区域分析/见解
对乙内酰脲抗惊厥药市场进行了分析，并按国家、药物、应用、剂量、给药途径、最终用户和分销渠道提供了市场规模洞察和趋势，如上所述。
乙内酰脲抗惊厥药市场报告涉及的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区
由于癫痫病的发病率不断上升，北美在乙内酰脲抗惊厥药市场占据主导地位。此外，主要关键参与者的不断增加和完善的医疗保健基础设施将进一步推动该地区市场的增长率。
由于医疗保健支出的增加和医疗保健基础设施的改善，预计亚太地区在 2022-2029 年预测期内将实现增长。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
竞争格局和乙内酰脲抗惊厥药市场份额分析
乙内酰脲抗惊厥药市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对乙内酰脲抗惊厥药市场的关注有关。
乙内酰脲抗惊厥药市场的一些主要参与者包括：
- 默克集团（德国）
- 卫材株式会社（日本）
- 阿斯利康（英国）
- 赛诺菲（法国）
- 诺华公司（瑞士）
- 雅培（美国）
- F. Hoffmann-La Roche Ltd.（瑞士）
- Teva Pharmaceutical Industries Ltd.（爱尔兰）
- 辉瑞公司（美国）
- 葛兰素史克公司 (英国)
- 沃克哈特（孟买）
- 诺和诺德公司（丹麦）
- Glenmark 制药有限公司（印度）
- Cipla Inc.（美国）
- Bausch Health Companies Inc.（加拿大）
- 大冢美国制药公司（美国）
- 强生私人有限公司（美国）
- 武田药品工业株式会社 (日本)
- 住友公司（日本）
- Biocon（印度）
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
